A Phase I Study of Imatinib, Dacarbazine, and Capecitabine in Advanced Endocrine Cancers

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author HALPERIN, Daniel M.
HOFF, Paulo FMUSP-HC
HOFF, Ana O. FMUSP-HC
PHAN, Alexandria
YAO, James C.
dc.date.issued 2014
dc.identifier.citation PANCREAS, v.43, n.3, p.496-496, 2014
dc.identifier.issn 0885-3177
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/8070
dc.language.iso eng
dc.publisher LIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartof Pancreas
dc.rights restrictedAccess
dc.title A Phase I Study of Imatinib, Dacarbazine, and Capecitabine in Advanced Endocrine Cancers
dc.type conferenceObject
dc.rights.holder Copyright LIPPINCOTT WILLIAMS & WILKINS
dc.description.conferencedate OCT 4–5, 2013
dc.description.conferencelocal Charleston, South Carolina, USA
dc.description.conferencename 6th Annual Meeting of the North American NeuroEndocrine Tumor Society
dc.description.group LIM/24
dc.type.category meeting abstract
dc.type.version publishedVersion
hcfmusp.author HOFF, Paulo:FM:MDR
hcfmusp.author HOFF, Ana O.:HC:ICESP
hcfmusp.author.external · HALPERIN, Daniel M.:Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
· PHAN, Alexandria:Baylor Univ, Methodist Hosp, Dept Med, Div Hematol Oncol, Houston, TX 77030 USA
· YAO, James C.:Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
hcfmusp.origem.id WOS:000333166800048
hcfmusp.publisher.city PHILADELPHIA
hcfmusp.publisher.country USA
dc.description.index MEDLINE
dc.identifier.eissn 1536-4828
hcfmusp.citation.wos 0
hcfmusp.affiliation.country Brasil
hcfmusp.affiliation.country Estados Unidos


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics